Vinblastine

Back to search

Molecule Structure

Scientific Name

Vinblastine

Description of the Drug

Vinblastine is a vinca alkaloid used to treat breast cancer, testicular cancer, neuroblastoma, Hodgkin’s and non-Hodgkins lymphoma, mycosis fungoides, histiocytosis, and Kaposi’s sarcoma.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB00570

Brand Name(s)

Not Available

Company Owner(s)

Hikma Pharmaceuticals Usa Inc, Abraxis Pharmaceutical Products, Hospira Inc, Fresenius Kabi Usa Llc, Eli Lilly And Co

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Tubulin PROTEIN COMPLEX GROUP INHIBITOR CHEMBL2095182

Unichem Links

SureChEMBL SCHEMBL3628
WDI EPIVINCOV
DrugBank DB00570
PubChem: Thomson Pharma 15945566 16702846
PubChem 13342
Mcule MCULE-9967454324
LINCS LSM-6068
Nikkaji J2.533.893F J1.596.263A
PDBe VLB
EPA CompTox Dashboard DTXSID8021430
DrugCentral 2823
Brenda 32422 230203 38815 6745 230202
Guide to Pharmacology 6851
GSRS 34be46f4-df27-4967-b8bd-5e0d9c6b2128
rxnorm VINBLASTINE SULFATE VINBLASTINE
ZINC ZINC000085432544